From: Fauci, Anthony (NIH/NIAID) [E]

Sent: Wed, 26 Feb 2020 18:25:04 +0000

To: Billet, Courtney (NIH/NIAID) [E]

Ce: Folkers, Greg (NIH/NIAID) [E];Conrad, Patricia (NIH/NIAID) [E];Marston, Hilary
(NIH/NIAID) [E];Routh, Jennifer (NIH/NIAID) [E];Stover, Kathy (NIH/NIAID) [E]

Subject: RE: Sec. Azar press briefing remarks

Attachments: 2 26 20 press briefing remarks - with Fauci edits.docx

Here are my edits.

Anthony S. Fauci, MD

Director

National Institute of Allergy and Infectious Diseases
Building 31, Room 7A-03

31 Center Drive, MSC 2520

National Institutes of Health

Bethesda, MD 20892-2520

Phone: <9
FAX: (301) 496-4409
E-mail:[
The information in this e-mail and any of its attachments is confidential and may contain sensitive
information. It should not be used by anyone who is not the original intended recipient. If you
have received this e-mail in error please inform the sender and delete it from your mailbox or any
other storage devices. The National Institute of Allergy and Infectious Diseases (NIAID) shall not
accept liability for any statements made that are the sender's own and not expressly made on
behalf of the NIAID by one of its representatives.

 

  

From: Billet, Courtney (NIH/NIAID) [E][ Cy@>

Sent: Wednesday, February 26, 2020 1:12 PM
To: Fauci, Anthony (NIH/NIAID) (EJ 00) 6)
Ce: Folkers, Greg (NIH/NIAID) [E] , IOS Conrad, Patricia (NIH/NIAID) [E]

CY) >; Marston, Hilary (NIH/NIAID) (E] [E> Routh, Jennifer
(NIH/NIAID) (E] {OF G; Stover, Kathy (NIH/NIAID) [€] (E>

Subject: ASF: Sec. Azar press briefing remarks

 

 

These are Sec Azar’s remarks for press tonight. (Plan still evolving.)

They are asking for our comments back by 2:45 pm. New content is highlighted to make it easier on
reviewers.

We’re sending your talking points down there momentarily.

From: Brennan, Patrick (OS/ASPA)[-___————« CF

Sent: Wednesday, February 26, 2020 1:07 PM

To: Conrad, Patricia (NIH/NIAID) [€] >; Bonds, Michelle E. (CDC/OD/OADC)
CG >; Galatas, Kate (CDC/OD/OADC) (IO E)>; Billet, Courtney (NIH/NIAID) [E]
CO C)>; Michael, Gretchen (OS/ASPR/OEA) {19}; Janik,

Heather (FDA/OC) r 6}>; Caliguiri, Laura (FDA/OC)

 

NIH-001307
